A

Alector

Biopharmaceutical R&D for neurodegenerative therapies

Senior Associate Scientist - Bioanalytical Sciences

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA$125k - $140k /yr

About the Job

Requirements

  • A BS in Biology, Biochemistry, Pharmacology, Immunology, or a related scientific discipline with 5+ years of relevant biotechnology or pharmaceutical industry experience, or an MS in a related scientific discipline with 3+ years of relevant industry experience.
  • Demonstrated ability to independently develop PK, ADA, and/or biomarker assays in biological samples including CSF, serum/plasma, and tissue lysates, with hands-on experience designing, developing, optimizing, troubleshooting, and qualifying assays rather than only executing established methods.
  • Direct bioanalytical experience supporting therapeutic modalities such as antibodies, bispecific antibodies, and/or conjugated siRNA.
  • Strong hands-on experience with ligand-binding assay platforms such as ELISA and MSD, including evaluation of sensitivity, selectivity, precision, matrix effects, drug tolerance, and assay interference.
  • Experience authoring and reviewing bioanalytical method protocols, qualification and validation plans, SOPs, data summaries, and technical reports.
  • Strong knowledge of GLP requirements and FDA, ICH, and EMA regulatory guidance related to bioanalytical assay development, qualification, and validation.
  • Experience working with external CROs on assay transfer, validation, sample analysis, troubleshooting, and data review.
  • Strong experimental documentation and communication skills.
  • Active use of large language models and a strong interest in evolving AI.

Responsibilities

  • Independently design, develop, optimize, troubleshoot, and qualify ligand-binding PK, ADA, and biomarker assays across biological matrices including CSF, serum/plasma, and tissue lysates.
  • Apply bioanalytical expertise to antibodies, bispecific antibodies, conjugated siRNAs, and other emerging therapeutic approaches.
  • Plan and execute laboratory experiments using platforms such as ELISA and MSD, evaluate assay performance, investigate matrix effects and interference, and deliver reproducible, decision-ready data.
  • Coordinate assay transfer, validation, sample analysis, troubleshooting, data review, timelines, and study deliverables with CRO partners while maintaining scientific ownership and supporting work conducted in accordance with applicable GLP and regulatory expectations.
  • Integrate laboratory automation, AI, and large language models to accelerate assay development, improve quality, and use resources more effectively.
  • Partner with colleagues across Research, Toxicology, Clinical Development, and multidisciplinary teams.
  • Communicate experimental results, assay limitations, risks, and recommendations clearly.

Desired Qualifications

  • Experience developing neutralizing antibody assays or other immunogenicity assessments.
  • Experience supporting regulated bioanalytical method validation and sample analysis.
  • Experience with automated liquid- or sample-handling platforms such as Agilent Bravo, Hamilton, or Tecan.
  • Experience with Gyrolab and fit-for-purpose biomarker assay qualification.
  • Experience with Benchling, Watson LIMS, GraphPad Prism, SoftMax Pro, or comparable electronic laboratory and bioanalytical data systems.
  • Experience introducing new assay technologies, automation, or data-analysis approaches into laboratory workflows.

About the Company

Alector

Biopharmaceutical R&D for neurodegenerative therapies

Alector is a biopharmaceutical company that develops therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. It uses insights from immunology, neurology, and human genetics to create medicines that help the body heal itself. The company focuses on researching and developing novel therapeutic candidates, mainly through early-stage clinical trials to quickly gather disease-specific data and improve the chances of success. Revenue and funding come from partnerships, grants, and eventual product commercialization. Alector aims to advance treatments for unmet medical needs in neurodegenerative diseases by pursuing a pipeline that combines scientific findings with strategic drug development.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Alector

See more jobs